Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study

J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e806-e808. doi: 10.1111/jdv.18285. Epub 2022 Jun 16.

Authors

E Sánchez-Meza¹, J Ocampo-Candiani¹, M Gómez-Flores¹, M E Herz-Ruelas¹, J Ocampo-Garza¹, T L Orizaga-Y-Quiroga¹, A Martínez-Moreno¹, S S Ocampo-Garza¹

Affiliation

¹ Department of Dermatology, Hospital Universitario 'Dr. José Eleuterio González', Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico.

PMID: 35648446
DOI: 10.1111/jdv.18285

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Administration, Topical
Alopecia* / drug therapy
Double-Blind Method
Dutasteride / therapeutic use
Finasteride* / therapeutic use
Humans
Minoxidil / therapeutic use
Treatment Outcome

Substances

Finasteride
Minoxidil
Dutasteride